Trial Profile
Long-term study of HP-3150 in patients with cancer pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2016
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 30 Nov 2016 Status changed from recruiting to completed.
- 08 Jun 2016 New trial record